Bay Street News, 2020

MORRIS PLAINS, N.J., Sept. 18, 2020 (GLOBE NEWSWIRE) — Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical […]

MALVERN, Pa., Sept. 18, 2020 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute […]

GAINESVILLE, Ga., Sept. 18, 2020 (GLOBE NEWSWIRE) — Recro (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrated […]

SAN DIEGO, Sept. 18, 2020 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record […]

—Advancing VERU-111 to a Pivotal Phase 3 Clinical Program—MIAMI, Sept. 18, 2020 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), an […]

TORONTO, Sept. 18, 2020 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company“) announces pursuant […]

FLORIANÓPOLIS, Brazil, Sept. 18, 2020 (GLOBE NEWSWIRE) — Vitru Limited (“Vitru”), a Brazilian distance learning education group company, today announced […]

Summit Therapeutics Inc.(“Summit” or the “Company”)Summit Announces Effectiveness of Scheme of Arrangement and Completion of Redomiciliation to Delaware, USACambridge, MA, […]

– Interim data showed meaningful clinical activity of AL101 4mg monotherapy with deep responses and 68% disease control rate– Company to host […]

NEW YORK, Sept. 18, 2020 (GLOBE NEWSWIRE) — Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro […]